References of "2003"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailPhosphate mineral occurrences in Lake Baïkal sediments : Paleo-environment or diagenesis record ?
Fagel, Nathalie ULg; Alleman, L. Y.; André, Luc et al

Poster (2003)

Detailed reference viewed: 21 (0 ULg)
Full Text
Peer Reviewed
See detailRENO, a European Postmarket Surveillance Registry, confirms effectiveness of coronary brachytheraypy in routine clinical practice.
Coen, V; Serruys, P; Sauerwein, W et al

in International Journal of Radiation, Oncology, Biology, Physics (2003), 55(4), 1019-1026

Purpose: To assess, by a European registry trial, the clinical event rate in patients with discrete stenotic lesions of coronary arteries (de novo or restenotic) in single or multiple vessels (native or ... [more ▼]

Purpose: To assess, by a European registry trial, the clinical event rate in patients with discrete stenotic lesions of coronary arteries (de novo or restenotic) in single or multiple vessels (native or bypass grafts) treated with -radiation. Methods and Materials: Between April 1999 and September 2000, 1098 consecutive patients treated in 46 centers in Europe and the Middle East with the Novoste Beta-Cath System were included in Registry Novoste (RENO). Results: Six-month follow-up data were obtained for 1085 patients. Of 1174 target lesions, 94.1% were located in native vessels and 5.9% in a bypass graft; 17.7% were de novo lesions, 4.1% were restenotic, and 77.7% were in-stent restenotic lesions. Intravascular brachytherapy was technically successful in 95.9% of lesions. Multisegmental irradiation, using a manual pullback stepping maneuver to treat longer lesions, was used in 16.3% of the procedures. The in-hospital rate of major adverse cardiac events was 1.8%. At 6 months, the rate was 18.7%. Angiographic follow-up was available for 70.4% of the patients. Nonocclusive restenosis was seen in 18.8% and total occlusion in 5.7% of patients. A combined end point for late (30–180 days) definitive or suspected target vessel closure was reached in 5.4%, but with only 2% of clinical events. Multivariate analysis was performed for major adverse cardiac events and late thrombosis. Conclusion: Data obtained from the multicenter RENO registry study, derived from a large cohort of unselected consecutive patients, suggest that the good results of recent randomized controlled clinical trials can be replicated in routine clinical practice. © 2003 Elsevier Science Inc. [less ▲]

Detailed reference viewed: 41 (0 ULg)
Full Text
See detailOntologie et phénoménologie dans la pensée de Saussure
Badir, Sémir ULg

in Bouquet, Simon (Ed.) Saussure (2003)

Detailed reference viewed: 41 (1 ULg)
Peer Reviewed
See detailDysregulation of inflammation
Bureau, Fabrice ULg; Lekeux, Pierre ULg

in Hoffman, A.; Robinson, N. E.; Wade, J. F. (Eds.) Proceedings of a Workshop on “Inflammatory Airway Disease: Defining the Syndrome”, Havemeyer Foundation Monograph Series No. 9 (2003)

Detailed reference viewed: 20 (2 ULg)
Full Text
Peer Reviewed
See detailComparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study
Hosking, D.; Adami, S.; Felsenberg, D. et al

in Current Medical Research & Opinion (2003), 19(5), 383-394

Objective: To compare the effects of alendronate (ALN) 70 mg once weekly (OW) and risedronate (RIS) 5 mg daily between-meal dosing on biochemical markers of bone turnover and bone mineral density (BMD) in ... [more ▼]

Objective: To compare the effects of alendronate (ALN) 70 mg once weekly (OW) and risedronate (RIS) 5 mg daily between-meal dosing on biochemical markers of bone turnover and bone mineral density (BMD) in postmenopausal women with osteoporosis. Research design and methods: This was a 3-month, randomised, double-blind, placebo-controlled study with a double-blind extension to 12 months. The study enrolled 549 postmenopausal women (ALN 219, RIS 222 and placebo (PBO) 108) who were : 60 years of age at outpatient centres. Main outcome measures: The primary endpoint was reduction in urine N-telopeptides of type 1 collagen (NTx) corrected for creatinine level at 3 months. Secondary parameters included change in BMD at the spine and hip at 6 and 12 months, NTx at 1, 6 and 12 months, and serum bone-specific alkaline phosphatase (BSAP) at 1, 3, 6 and 12 months. Adverse experiences (AEs) were recorded throughout the study for an assessment of treatment safety profiles and tolerability. Results: Over 3 months, ALN produced a significantly greater mean reduction in urine NTx than did RIS (-52% vs -32%, p < 0.001), which was maintained at 12 months. ALN produced a significantly greater mean BMD increase than did RIS at 6 months, and it was maintained at 12 months at the lumbar spine (4.8% vs 2.8%, p < 0.001) and total hip (2.7% vs 0.9%, p < 0.001), as well as at the trochanter and femoral neck. Significant reductions in BSAP with ALN compared to RIS were maintained over the 12 months of treatment. Study size did not allow for meaningful assessment of differences in fracture rates. Tolerability was generally similar between ALN, RIS and PBO, and the incidence of upper GI AEs causing discontinuation and oesophageal AEs was similar in the ALN and RIS groups. Conclusion: In this study, ALN 70 mg OW produced a 50% greater reduction in bone resorption as measured by urine NTx and significantly greater increases in lumbar spine and hip BMD than did RIS 5 mg daily. The treatments had similar safety profiles and were generally well-tolerated. Additional studies are needed comparing OW ALN with OW RIS, which became available after the commencement of the present study. [less ▲]

Detailed reference viewed: 18 (2 ULg)
Full Text
Peer Reviewed
See detailCell Handling, Membrane-Binding Properties, And Membrane-Penetration Modeling Approaches Of Pivampicillin And Phthalimidomethylampicillin, Two Basic Esters Of Ampicillin, In Comparison With Chloroquine And Azithromycin
Chanteux, H.; Paternotte, I.; Mingeot-Leclercq, Mp. et al

in Pharmaceutical Research (2003), 20(4), 624-31

PURPOSE: The purpose of this work was to examine and understand the cellular pharmacokinetics of two basic esters of ampicillin, pivaloyloxymethyl (PIVA) and phthalimidomethyl (PIMA), in comparison with ... [more ▼]

PURPOSE: The purpose of this work was to examine and understand the cellular pharmacokinetics of two basic esters of ampicillin, pivaloyloxymethyl (PIVA) and phthalimidomethyl (PIMA), in comparison with lysosomotropic drugs (chloroquine, azithromycin). METHODS: Cell culture studies (J774 macrophages) were undertaken to study uptake and release kinetics and to assess the influence of concentration, pH, proton ionophore (monensin), and MRP and P-gp inhibitors (probenecid, gemfibrozil, cyclosporin A, GF 120918). Equilibrium dialysis with liposomes were performed to directly asses the extent of drug binding to bilayers. Conformational analysis modeling of the drug penetration in bilayers was conducted to rationalize the experimental observations. RESULTS: PIVA and PIMA showed properties in almost complete contrast with those of chloroquine and azithromycin, i.e., fast apparent accumulation and fast release at 4 degrees C as well as at 37 degrees C, saturation of uptake (apparent Kd 40 microM), no influence of monensin, MRP, or P-gp inhibitors; tight binding to liposomes (Kd approx. 40 microM); and sharp increase in calculated free energy when forced in the hydrophobic domain. CONCLUSIONS: Although they are weak organic bases, PIVA and PIMA show none of the properties of lysosomotropic agents. We hypothesize that they remain locked onto the pericellular membrane and may never penetrate cells as such in significant amounts. [less ▲]

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailPregnancy-Associated Glycoprotein 60f [Fragment] from Ovis aries placenta - Access number P83498
El Amiri, B.; Remy, B.; Melo de Sousa, Noelita ULg et al

E-print/Working paper (2003)

N-terminal microsequence obtained after purification and characterization of placental proteins in ovine species. Proteins were submitted to SwissProt databank.

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailModélisation 3D d’un groupe de pieux pour le pont-canal de Houdeng
Trevisan, Stefano; Li, Xian Ling; Collin, Frédéric ULg et al

in Revue Française de Géotechnique (2003), 105

A satisfactory prediction of the settlements of hyperstatic structures is becoming more and more important in their design and construction. In this paper, the problems related to the behaviour of a group ... [more ▼]

A satisfactory prediction of the settlements of hyperstatic structures is becoming more and more important in their design and construction. In this paper, the problems related to the behaviour of a group of piles and to the quality of the drilled piles of the canal-bridge of Houdeng (Belgium) are analysed in a non conventional fashion, based on a finite element analysis, thanks to sufficient experimental data. The influence of an imperfectly cleaned excavation bottom and of the destructuration of the bottom rocks caused by the drilling of the piles is investigated. A particular attention is also given to the behaviour of a group of piles. [less ▲]

Detailed reference viewed: 173 (20 ULg)
Full Text
Peer Reviewed
See detailObservation récente en Province de Liège de Velleius dilatatus (F., 1787) (Coleoptera: Staphylinidae)
Thieren, Yves; Fagot, Jean ULg; Lhoir, Jonathan

in Notes Fauniques de Gembloux (2003), 50

Detailed reference viewed: 21 (1 ULg)
Full Text
Peer Reviewed
See detailJL 13, an atypical antipsychotic: A preclinical review
Ellenbroek, B. A.; Liégeois, Jean-François ULg

in Cns Drug Reviews (2003), 9(1, Spring), 41-56

The extensive pharmacological evaluation of JL 13 as an atypical antipsychotic drug has revealed a close similarity to clozapine, however with some major advantages. JL 13 was characterized as a weak D-2 ... [more ▼]

The extensive pharmacological evaluation of JL 13 as an atypical antipsychotic drug has revealed a close similarity to clozapine, however with some major advantages. JL 13 was characterized as a weak D-2 antagonist, both in vitro and in vivo, with a strong affinity for the D-4 and the 5-HT2A receptors. It has no affinity for the 5-HT2C receptor. In vivo microdialysis experiments in rat showed that JL 13, like clozapine, preferentially increased extracellular dopamine concentrations in the prefrontal cortex compared to nucleus accumbens or striatum. Behavioral studies showed that JL 13, like clozapine, has the profile of an atypical antipsychotic. Thus, JL 13 did not antagonize apomorphine-induced stereotypy nor did it produce catalepsy, but it antagonized apomorphine-induced climbing in rodents. It was inactive against d-amphetamine-induced stereotypy but antagonized d-amphetamine-induced hyperactivity in the mouse. Likewise, in the paw test, it was more effective in prolonging hindlimb retraction time than prolonging forelimb retraction time. Like other antipsychotic drugs, JL 13 reversed the apomorphine- and amphetamine-induced disruption of prepulse inhibition. In a complex temporal regulation schedule in the dog, JL 13 showed a high resemblance with clozapine without inducing sialorrhea, palpebral ptosis or any significant motor side effects. In rats and squirrel monkeys JL 13 induced a high degree of generalization (70%) to clozapine. Regarding behavioral toxicology, JL 13 did not produce dystonia or Parkinsonian symptoms in haloperidol-sensitized monkeys. After acute administration, again like clozapine, JL 13 induced only a transient increase in circulating prolactin. Last but not the least, regarding a possible hematological toxicity, unlike clozapine, JL 13 did not present sensitivity to peroxidase-induced oxidation. Moreover, its electrooxidation potential was close to that of loxapine and far from that of clozapine. Taking all these preclinical data into account, it appears that JL 13 is a promising atypical antipsychotic drug. [less ▲]

Detailed reference viewed: 44 (3 ULg)
See detailL’information sous contrôle. Médias et pouvoir économique en Belgique
Geuens, Geoffrey ULg

Scientific conference (2003)

Detailed reference viewed: 41 (12 ULg)
See detailAnalysis of peer interaction among children in a tutoring situation pertaining to mathematical problems of the multiplying type
Crahay, Marcel ULg; Hindryckx, Geneviève ULg; Lebe, Martine

in De Corte, E. (Ed.) Powerful learning environments : unravelling basic components and dimensions (2003)

Detailed reference viewed: 23 (0 ULg)
See detailFengycin penetration into a DPPC monlayer: a study using the Langmuir trough technique with the Brewster angle microscopy
Deleu, Magali ULg

in International symposium on surface and colloid chemistry for the life sciences (2003)

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailL'application dans le temps de la peine de travail
Jacobs, Ann ULg

in Revue de Droit Pénal et de Criminologie (2003)

Detailed reference viewed: 33 (3 ULg)
Full Text
See detailXylobios: patterns, roles and determinants of saproxylic diversity in Belgian deciduous forests
Fayt, Philippe; Branquart, Etienne; Dufrêne, Marc ULg et al

in McManus, M.L.; Liebhold, A.M. (Eds.) Proceedings: Ecology, Survey and Management of Forest Insects (2003)

Detailed reference viewed: 16 (3 ULg)
Peer Reviewed
See detailL'iconographie du meurtre de saint Lambert de Liège
George, Philippe ULg

in Bischofsmord im Mittelalter. Murder of Bishops, 22 septembre 2000 (2003)

Detailed reference viewed: 36 (3 ULg)